← Back
Data updated: Mar 10, 2026
CIS
RespiratoryOncologyOphthalmology
CIS is a pharmaceutical company focused on Respiratory, Oncology, Ophthalmology.
1976
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 60%
0 drugs Phase 3: 16 Phase 2: 14 Phase 1: 27
Oncology 22%
0 drugs Phase 3: 2 Phase 2: 3 Phase 1: 29
Ophthalmology 9%
0 drugs Phase 3: 2 Phase 2: 4 Phase 1: 1
Metabolic 6%
0 drugs Phase 2: 5 Phase 1: 1
Infectious Disease 5%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 3
Pipeline Strength Pro
Loading...
Competitors Pro
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease, Respiratory
Novartis big-pharma
Oncology, Ophthalmology, Respiratory
Merck big-pharma
Oncology, Infectious Disease, Metabolic
Baxter specialty
Infectious Disease, Oncology, Ophthalmology
AbbVie big-pharma
Oncology, Infectious Disease, Ophthalmology
Active (0)
Discontinued (1)
Company Info
- First Approval
- 1976-11-09
- Latest
- 1985-03-05
- Applications
- 1